Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patients

By Serretta V.   Lo Presti D.   Vasile P.   Gange E.   Esposito E.   Menozzi I.  

Urology, Vol. 52, Iss. 5, 1998-11 ,pp. : 793-796

Elsevier

Access to resources Recommend Favorite

Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma

By Kaya K.   Ayan S.   Gokce G.   Kilicarslan H.   Yildiz E.   Gultekin E. Y.  

Scandinavian Journal of Urology and Nephrology, Vol. 39, Iss. 1, 2005-02 ,pp. : 25-29

Informa Healthcare

Access to resources Recommend Favorite

Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma (RCC)

By Terrone C.   Guercio S.   De Luca S.   Castelli E.   Scoffone C.   Tarabuzzi R.   Porpiglia F.   Scarpa R.   Fontana D.   Rocca Rossetti S.   Poggio M.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 138-138

Elsevier

Access to resources Recommend Favorite

Clinical significance of urinary vascular endothelial growth factor and microvessel density in patients with renal cell carcinoma

By Chang S.-G.   Jeon S.-H.   Lee S.-J.   Choi J.-M.   Kim Y.-W.  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 904-908

Elsevier

Access to resources Recommend Favorite

Lymphocyte subpopulations: prognostic value of patients with renal cell carcinoma under therapy with IL-2 and IFN-alpha

By Hillig F.   Schneider T.   Zacharias M.   Langner J.   Fornara P.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 141-141

Elsevier

Access to resources Recommend Favorite